Orchard Therapeutics plc Quarterly Amortization of Intangible Assets in USD from Q1 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Orchard Therapeutics plc quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2022 to Q3 2023.
  • Orchard Therapeutics plc Amortization of Intangible Assets for the quarter ending September 30, 2023 was $100K, unchanged year-over-year.
  • Orchard Therapeutics plc Amortization of Intangible Assets for the twelve months ending September 30, 2023 was $300K.
  • Orchard Therapeutics plc annual Amortization of Intangible Assets for 2022 was $300K, a 50% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $300K $100K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $300K $100K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $300K $100K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $300K $0 Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 $100K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $100K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $100K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.